Formulation development
Stemmatters has established mimsys® as a formulation development platform for regenerative medicine applications. mimsys® addresses ample application opportunities along the manufacturing cycle of advanced therapies, including cell expansion, cell storage and formulation of end-products.
Why mimsys®?
High Biocompatibility
Minimal cytotoxicity and low immunogenicity, suitable for direct cell contact applications.
Versatile Platform
Versatile chemo-selective modification supporting multiple intended uses.
Mechanical Performance
Adjustable stiffness and elasticity, mimicking natural tissues and extracellular matrix.
Sterilisation Compatible
Effective with various sterilisation methods, ensuring safety for clinical use.
Simple Administration
Supports easy administration through minimally invasive procedures.
Structural Retention
Provides local retention at site of implantation.
Efficient development roadmaps
With extensive experience in rational design optimisation, we efficiently design, test, and iterate on candidates tailored to specific target product profiles and end-use applications. For each project, Stemmatters establishes a well-defined and structured development roadmap aimed at advancing candidates toward successful applicational development.
Stemmatters is strongly committed to establishing new product development collaborations with third parties. We invite you to reach out and start the conversation with us.
Ready to transform your vision into reality?
Get in touch to learn more about our work and how we can collaborate.